MedTrace Logo

Gestational Immunity for Transfer

NCT04802278 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-03-17

No results posted yet for this study

Summary

This is a study prospective cohort study at an urban academic centre, with two parts:

1. Health outcomes, and maternally transferred antibodies, in babies born to mothers who had antenatal COVID-19 and convalesced before delivery, followed up until 12 months of age
2. Safety and protective properties of breast milk after lactating women are vaccinated against COVID-19

Conditions

  • Covid19
  • Breastfeeding
  • Vaccine Exposure Via Breast Milk

Interventions

BIOLOGICAL

COVID-19 vaccine

Any COVID-19 vaccine

Sponsors & Collaborators

  • National University of Singapore

    collaborator OTHER

  • Agency for Science, Technology and Research

    collaborator OTHER

  • National University Hospital, Singapore

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-06-01
Completion
2021-12-01

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04802278 on ClinicalTrials.gov